COURTNEY WHARTON: Open Payments
NPI 1306255393 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 47 payments from 14 companies in 2025. Trend: 2023 $30 · 2024 $583 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $203 |
| PFIZER INC. | 12 | $185 |
| Lilly USA, LLC | 8 | $151 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Novo Nordisk Inc | 2 | $30 |
| Exact Sciences Corporation | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, NURTEC ODT, PREVNAR 20, JARDIANCE, ETERNA, AREXVY, FARXIGA.
Industry payments across NC — which companies pay providers there.
